We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$759M
AUM Growth
-$29.3M
Cap. Flow
+$33.1M
Cap. Flow %
4.37%
Top 10 Hldgs %
97.83%
Holding
21
New
2
Increased
9
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
AGEN
Agenus
AGEN
+$25.4M
2
OPK icon
Opko Health
OPK
+$5.53M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$4.14M
4
PACB icon
Pacific Biosciences
PACB
+$2.31M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$2.25M

Top Sells

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$6.91M
2
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$5.61M
3
QDEL icon
QuidelOrtho
QDEL
+$4.6M

Sector Composition

Rank Sector Weight
1 Healthcare 99.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$394M 51.91%
1,795,462
-20,632
-1% -$4.6M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$135M 17.77%
2,074,800
+63,100
+3% +$4.14M
AGEN
3
Agenus
AGEN
$275M
$52.5M 6.92%
669,223
+326,714
+95% +$25.4M
OPK icon
4
Opko Health
OPK
$1.25B
$49.3M 6.49%
13,355,773
+1,309,887
+11% +$5.53M
AXDX
5
DELISTED
Accelerate Diagnostics
AXDX
$43.6M 5.75%
409,175
+2,281
+0.6% +$317K
AWH
6
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$26.7M 3.52%
576,518
-109,388
-16% -$5.61M
PACB icon
7
Pacific Biosciences
PACB
$432M
$17M 2.24%
1,721,459
+401,100
+30% +$2.31M
SLNO
8
DELISTED
Soleno Therapeutics
SLNO
$9.21M 1.21%
244,692
– –
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$2.48B
$8.68M 1.14%
2,525,857
+525,857
+26% +$2.25M
QDEL icon
10
CALL
QuidelOrtho
QDEL
$1.14B
$6.65M 0.88%
228,000
+36,700
+19% +$8.19M
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
$4.59M 0.6%
1,699,566
– –
AMRN
12
Amarin Corp
AMRN
$293M
$4.28M 0.56%
50,775
-57,632
-53% -$6.91M
MOTS
13
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$3.72M 0.49%
12,689
– –
BIIB icon
14
Biogen
BIIB
$30.4B
$1.05M 0.14%
3,688
– –
YMAB
15
DELISTED
Y-mAbs Therapeutics
YMAB
$968K 0.13%
25,212
– –
CFRX
16
DELISTED
ContraFect Corporation
CFRX
$885K 0.12%
2,095
+484
+30% +$220K
BIOL
17
DELISTED
Biolase, Inc.
BIOL
$478K 0.06%
696
– –
BHVN
18
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$423K 0.06%
68,100
+5,000
+8% +$328K
AGEN
19
CALL
Agenus
AGEN
$275M
$39K 0.01%
+5,360
New +$417K
AMRN
20
CALL
Amarin Corp
AMRN
$293M
$8K ﹤0.01%
+15,265
New +$1.83M
AXDX
21
CALL
DELISTED
Accelerate Diagnostics
AXDX
– –
-13,790
Closed -$686K

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Oracle Investment Management held 21 positions worth $759M, down 3.7% from $788M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Oracle Investment Management deployed $33.1M of net new capital in Q3 2020, opening 2 new positions and adding to 9 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier.

On the sell side, the largest reduction was Amarin Corp, an estimated $6.91M trimmed.

  • Oracle Investment Management added most to Agenus in Q3 2020, an estimated $25.4M increase.
  • Oracle Investment Management's biggest Q3 2020 reduction was Amarin Corp, cutting an estimated $6.91M.
  • Oracle Investment Management's ten largest holdings make up 98% of its $759M portfolio in Q3 2020.
  • Oracle Investment Management opened 2 new positions and closed 1 in Q3 2020.
  • Oracle Investment Management's portfolio value fell 3.7% quarter-over-quarter to $759M.

Based on Oracle Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.